Notably, the frequency of tumors expressing a high level of NICD1 was increased among patients with elevated DCLK1 expression in both cohorts, further suggesting that in some cases, concurrent expression of DCLK1 and activation of NOTCH signaling may facilitate a rapidly progressing and aggressive tumor phenotype. This evidence concerns the gene DCLK1 and neoplasm.